News
Key Points Healthcare is a complex sector, but some dividend payers have proven incredibly reliable over the long ...
Trump has rolled back many of his steepest tariffs over recent months, including a sky-high levy on China, the top source of ...
In addition to these quarterly earnings, Merck & Co., Inc. (NYSE:MRK) has shown its resilience as a dividend stock. The ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Germany’s Merck KGaA is paying $45 million upfront for rights to a potentially first-in-class drug for colorectal cancer (CRC) being developed by New York biotech Inspirna. The agreement gives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results